Coca-Cola (KO) PT Raised to $100 at Morgan Stanley, 'Top Pick'
Get Alerts KO Hot Sheet
Rating Summary:
25 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst Dara Mohsenian raised the price target on Coca-Cola (NYSE: KO) to $100.00 (from $89.00) while maintaining a Overweight rating.
The analyst comments "Reiterate OW as Top Pick: KO's stock jumped 5.0% today (vs the S&P up +0.2%) on stronger than expected 2Q results driven by robust OSG. Even with a high bar, KO's Q2 results were impressive, with strong 5% unit case growth far above the 2.2% consensus, as well as Coke's 1.1% last nine quarter avg., and 7% OSG (using unit cases and 2% price/mix with 3% underlying price offset partially by -1% mix) above the 5.0% consensus. FY OSG of 5% moved to the high end of the prior 4-5% FY range but looks conservative, and comparable FY EPS moved up by ~100 bps. Q2 was boosted by an easy -1% unit case comparison, the World Cup, hot weather in Europe, and the America 250 celebration, but even after these factors, the level of Q2 unit case growth was still impressive, and Q2 tailwinds also drive strong visibility for Q3 given they continued in July. We also note Coke posted solid 3% unit case growth in Q1, which at the time was the strongest growth since the 3% result in Q1 of 2023. Bottom line, Coke's OSG remains in a different stratosphere than its megacap staples peers, and KO appears to be managing well the planned YTD shift in OSG balance more to volume from outsized price/mix in recent years. Net, the quarter instills further confidence in our view that Coke offers outsized OSG vs peers."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- enVVeno Medical (NVNO) files $100M mixed shelf
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Morgan Stanley, Standard & Poor's, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share